2Garewal H,Bemstein N,Bernstein C,et al.Reduced bile acid-induced apoptisis in “normal”colorectal mucosa:a potential biological marker for cancer risk [J].Cancer Res,1996,56:1480 ～1483.
3Hickman ES,Moroni MC,Helin K.The role of p53 and pRB in apoptosis and cancer [J].Curr Opin Genet Dev,2002,12 (1):60.
5Nagata N,Golstein P.The Fas death factor [J].Science,1995,267:1449 ～ 1456.
6Song E,Chen J,Duyang N,et al.Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis:a active mode of immune evasion in colon cancer[J].Br J Cancer,2001,85:1047 ～ 1054.
7Bennett MW,O Connell J,O Sullivan GC,et al.Expression of Fas (CD95/Apo-1)ligand by human gastric adenocarcinomas:a potential mechanism of immune escape in stomach cancer [J].Gut,1999,44:156 ～ 162.
2O'Connell J,Bennett M W,O'Sullivan G C, et al. Expression of Fas (CD95/APO-1) ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer [J]. Gut,1999,44:156-162.
3Connell J O, Bennett M W, Sullivan G C O, et al. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer [J]. J Pathol,1998,186:240-246.
4Shiraki K, Tsuj N, Shiode T, et al. Expression of Fas ligand in liver metastasis of human colonic adenocarcinomas [J]. Proc Natl Acad Sci USA, 2000,94:6420-6425.
5Cstherine G, Yasuo T, Christoph B, et al. Up-regulation of Fas(Apo-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer [J]. Cancer Research, 1998, 58:2057-2062.
6Gloria A N, Thomas B, Sandra P F, et al. human lung carcinomas express Fas ligand [J]. Cancer Research,1997,57:1007-1012.
7Glover C, Douse P, Kane P, et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum, 2002,45:476-484.
8Song E, Chen J, Ouyang N, et al. Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer. Br J Cancer, 2001,85:1047-1054.
9Oliver L, Cordel S, Barbieux I, et al. Resistance to apoptosis is increased during metastatic dissemination of colon cancer. Clin Exp Metastasis, 2002,19:175-180.
10Irmler M;Thome M;Hahne M.Inhibition of death receptor signals by cellular FLIP[J],1997(6638).
4[2]Muschen M,Moers C,Warskulat U,et al.CD95 ligand expression in dedifferentiated breast cancer.Pat hol,1999,189(3):378-386.
5[3]TanakaM,Suda T,Yatomi T,et al.Lethal effect of recombinant human Fas ligand in mice pretreated with Prop ionibacterium acnes.Immunol,1997,158(5):2303-2309.
6Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA or human cell surface antigen Fas can mediate apoptosis [J]. Cell, 1991, 66(2) : 233-243.
7Kim R, Emi M, Tanabe K, et al. The role of Fas ligand and transforming growth factor in tumor progression [ J ]. Cancer, 2004, 100 (11): 2281-2291.
8Sun T, Miao X, Zhang X, et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma [ J]. J Natl Cancer Inst, 2004, 96( 13): 1030-1036.
9Meterissian SH, Kontogiannea M, Po J, et al. Apoptosis induced in human colorectal carcinoma by anti-Fas antibody [ J]. Ann Surg Oncol, 1997, 4(2) : 169-175.
10Weller M, Malipiero U, Agazzi A, et ai. Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation [J]. J Clin Invest, 1995, 95(6) : 2633-2643.
